Breaking News

Evonik Bolsters Excipients Portfolio

Acquires Birmingham-based Lactel absorbable polymers from Durect Corporation.

By: Contract Pharma

Contract Pharma Staff

Evonik has signed an agreement to acquire the Lactel business of biodegradable polymers from Durect Corporation $15 million. The transaction is expected to close by the first quarter of 2021. An offer will be extended to each of the 15 employees of Durect located in Birmingham, AL, which are associated with the Lactel business to transition to the Evonik.   “The acquisition of the Lactel business will strengthen both our innovation growth field Healthcare Solutions and Evonik’s position as a glo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters